Cigna Corp vs Global X Uranium ETF — how do they compare? Cigna Corp trades at $273.05 (market cap $73.56B), while Global X Uranium ETF trades at $45.5. The key difference: Cigna Corp pays a 2.24% dividend while Global X Uranium ETF pays none. Which is the better fit depends on your goals.
| CI | URA | |
|---|---|---|
Market Cap | $73.56B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $311.00 | $61.81 |
52-Week Low | $244.41 | $36.45 |
Enterprise Value | $98.27B | — |
Dividend Yield | 2.24% | — |
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $278.40, down 1.45% on the day, with a bearish technical signal but strong fundamentals including a P/E of 11.51 and ROE of 15.49%. Recent Q2 2026 earnings beat expectations at $7.78 per share, and the company raised its full-year EPS guidance. The stock is supported by consistent dividend payments and robust cash flow from operations of $9.60 billion in 2025.
The outlook is positive with a consensus price target of $338.90, implying 22% upside. Key opportunities include steady earnings growth and capital returns, while risks involve healthcare cost pressures and competitive dynamics. Analyst sentiment is strongly bullish with 73.68% buy ratings, though technical indicators suggest near-term caution.
URA, the Global X Uranium ETF, trades at $45.63, up 2.82% with a bullish technical signal from moving averages. The ETF benefits from strong policy support including $17.5 billion in federal nuclear funding and growing AI power demand. Recent index additions like Terra Innovatum and Eagle Nuclear Energy expand exposure to nuclear supply chain companies. RSI_6 at 92.76 indicates potential short-term overbought conditions while ADX signals strong trend momentum.
The uranium sector outlook remains positive with nuclear energy positioned as a solution to AI power demands and global energy security needs. Key risks include ETF concentration in uranium miners and sensitivity to commodity price volatility. Support at $45 and resistance at $46 will be critical for near-term price direction as the sector capitalizes on nuclear renaissance tailwinds.
Trailing returns across standard periods
Latest headlines on both assets
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →URA provides broad exposure to the global uranium industry and nuclear energy sector. Unlike pure-play mining funds, it includes companies involved in nuclear component production and infrastructure, with top 2026 holdings such as Cameco, Oklo, and Uranium Energy Corp.
Read more on URA →